Pharma Financial Squeeze Bodes Ill for Genomics

Pharma Financial Squeeze Bodes Ill for Genomics
‘Caution: Tougher Times Ahead’ may be an apt sign for biotech in general and genomics in particular, according to a panel of leading venture capitalists.


Comments are closed.

Do NOT follow this link or you will be banned from the site!